BioStar Ventures
Startup rounds since 2012 with a BioStar Ventures investor on the board, and the firm's own fund filings.
Raises
37
since 2012
Unannounced
2
no announcement found, of those filed since 2025
Funds
4
fund filings under the firm's name
Rounds
- Ablative Solutions, Inc.$10.4M
- Aria CV, Inc.$1.38M
- Delphinus Medical Technologies, Inc.$27.6M
- Ablative Solutions, Inc.$37.2M
- Amplitude Vascular Systems, Inc.$23.6M
- Aria CV, Inc.$2.22M
- Ablative Solutions, Inc.$29.3M
- Delphinus Medical Technologies, Inc.$5M
- Amplitude Vascular Systems, Inc.$4.41M
- Delphinus Medical Technologies, Inc.$30.4M
- Aria CV, Inc.$7.77M
- Foldax, Inc.Undisclosed
- Ablative Solutions, Inc.$54.5M
- Calcium Solutions, Inc.$1.24M
- Aria CV, Inc.$667K
- Corindus Vascular Robotics, Inc.$414K
- Corindus Vascular Robotics, Inc.$4.85M
- Corindus Vascular Robotics, Inc.$15M
- Foldax, Inc.$10.3M
- Corindus Vascular Robotics, Inc.$180K
- Corindus Vascular Robotics, Inc.$25M
- Aria CV, Inc.$1.92M
- Ablative Solutions, Inc.$4.01M
- Neochord Inc$4.03M
- Delphinus Medical Technologies, Inc.$8.23M
- Corindus Vascular Robotics, Inc.$45M
- Ablative Solutions, Inc.$11.4M
- Ablative Solutions, Inc.$2.46M
- Delphinus Medical Technologies, Inc.$39.5M
- Kona Medical, Inc.$10M
- Neochord Inc$12.6M
- Neochord Inc$457K
- Ablative Solutions, Inc.$14.6M
- Great Lakes Pharmaceuticals, Inc.$11.2M
- Autonomix Medical, Inc.$3.8M
- Ablative Solutions, Inc.$3.05M
- Ablative Solutions, Inc.$990
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2025 | 3 | 2 |
| 2024 | 4 | — |
| 2023 | 1 | — |
| 2022 | 4 | — |
| 2021 | 1 | — |
| 2020 | 2 | — |
| 2019 | 3 | — |
| 2018 | 5 | — |
| 2017 | 4 | — |
| 2015 | 6 | — |
| 2014 | 2 | — |
| 2012 | 2 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| BioStar Ventures V, L.P. | 2 Dec 2022 | Open-ended | $78.5M |
| BioStar Ventures V-A, L.P. | 2 Dec 2022 | Open-ended | $10.2M |
| BioStar Ventures III-XF, L.P. | 11 Jun 2018 | $20M | — |
| BioStar Ventures III, L.P. | 16 Sep 2015 | $100M | $67.7M |
Listed because a BioStar Ventures fund's filing names a director of each company. A name match is not a verified identity.